Sunday, February 15

Deadly ‘ColdRif’ Cough Syrup Claims 24 Lives; 9 Arrested, Authorities Under Scrutiny

Chhindwara, Madhya Pradesh: In a shocking turn of events in the poisonous cough syrup case, the Special Task Force (STF) has made yet another significant arrest. A medical store owner from Parasia has been taken into custody, marking the ninth arrest in the case. The ingestion of the contaminated syrup, branded ‘ColdRif’, has tragically claimed the lives of 24 children.

Details of the Latest Arrest
The latest accused, Anil Rasela, owner of Rasela Medical on Station Road, Parasia, has been sent to judicial custody. Earlier, the STF had sealed Rasela Medical and revoked its drug license.

Previous STF Actions
Earlier, the STF had carried out actions linked to Shree San Pharma in Tamil Nadu. Shailesh Pandya, who supplied raw materials to the company, was arrested in connection with the production of ColdRif syrup. Investigations revealed that the syrup’s consumption had caused the death of 24 innocent children, sparking panic across Madhya Pradesh.

Nine Arrests So Far
So far, the STF has arrested the company owner, chemists, prescribing doctors, wholesale medicine traders, medical store operators, marketing representatives, and other personnel associated with drug distribution. Notably, doctor Praveen Soni and his wife, who runs a medical store, have also been apprehended.

Authorities Yet to Be Held Accountable
Despite these arrests, the drug controllers and inspectors from Tamil Nadu and Madhya Pradesh responsible for approving the syrup have not yet been arrested. The state government has suspended the officials, and sources indicate that their arrests could follow soon.

The case continues to raise serious questions about regulatory oversight and the accountability of officials in drug approval processes.


Discover more from SD NEWS agency

Subscribe to get the latest posts sent to your email.

Leave a Reply

Discover more from SD NEWS agency

Subscribe now to keep reading and get access to the full archive.

Continue reading